Experts weigh in Nov. 7 at 1 p.m. ET | This is your reminder to register for the FREE and LIVE webinar “Rescheduling or Descheduling: How Future Federal Decisions May Impact the Industry” produced by Cannabis Business Times and Cannabis Conference on Nov. 7 at 1 p.m. ET.
We’ll be covering the practical consequences of President Biden’s instruction to the secretary of Health and Human Services and attorney general to review cannabis’ Schedule I status in the Controlled Substances Act.
The big question here is: What does that mean for us?
Learn how your cannabis business can prepare for the future as we discuss the following: The actual process that the Biden administration is undertaking The ways in which rescheduling or descheduling cannabis would impact the industry The ways in which businesses can secure GMP compliance ahead of possible FDA oversight The ways in which access to capital may change under federal intervention The possible effects on interstate commerce and international trade |
MODERATOR:
Mason Walker
CEO, East Fork Cultivars |
|
SPEAKER:
Kris Krane
CEO and Principal, Kranewreck Enterprises
Founder of 4Front / Mission |
|
|
SPEAKER:
Wendy Bronfein
Chief Brand Officer and Director of Public Policy, Curio Wellness
Chair, National Medicinal Cannabis Coalition |
|
SPEAKER:
Jarrod Loadholt
Partner, Ice Miller’s Public Affairs Group |
|
| | |
|
|
